Variantyx

Framingham, MA · Founded 2014 · Privately Held (backing)

Developer of genetic testing platform designed to improve diagnosis and personalized medicine for rare genetic disorders, reproductive genetics and precision oncology. Variantyx is based in Framingham, MA and was founded in 2014. It was valued at $98 million at its later-stage round in Apr 2024, the last priced event on record. It has raised $175 million across 1 recorded round; the latest was a $15.6 million early-stage round in Feb 2021.

PMV mark · valuation
$98.0M
Oct 2026
Priced at
its later-stage round
Apr 2024
Total raised
$175.3M
Last round
Early Stage VC
Feb 2021
Cap table — not yet on record

Variantyx's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Variantyx with a free Private Market View account
  • ·The complete investor list: 11 names
  • ·Watch Variantyx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Variantyx

Where does Variantyx's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Variantyx's 1 recorded funding rounds.